Inventor
ZAHRA SHAHROKH
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides20%
C12NMicroorganisms or enzymes17%
C12YEnzymes17%
PatentTitleYear
12,409,210CNS delivery of therapeutic agents202512,383,620Phthalocyanine dye conjugate compositions202512,168,041Methods and compositions for CNS delivery of arylsulfatase A202412,161,702Methods and compositions for CNS delivery of heparan N-sulfatase202412,121,569Methods and compositions for CNS delivery of iduronate-2-sulfatase202411,471,516CNS delivery of therapeutic agents202211,260,112Methods and compositions for CNS delivery of iduronate-2-sulfatase202211,141,479Stable anti-OSMR antibody formulation2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to KINIKSA PHARMACEUTICALS LTD (1)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to SHIRE HUMAN GENETIC THERAPIES (2)· patent assignee history
2024–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (4)· patent assignee history
2025Patents assigned to RAKUTEN MEDICAL INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 4 | 2024–2025 |
| SHIRE HUMAN GENETIC THERAPIES | 2 | 2022 |
| KINIKSA PHARMACEUTICALS LTD | 1 | 2021 |
| RAKUTEN MEDICAL INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |